GlassScriptPhysician profile
Paul Himaya
NPI 1487677449
$1,465.62
in general payments reported to CMS, 2019-2025
11 companies · $22.83 in 2025
The $22.83 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $68.73 · 2021: $372 · 2022: $505 · 2023: $113 · 2024: $88.35 · 2025: $22.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $334.79 | 2021-2024 | Bis, Ligasure |
| Getinge USA Sales, LLC | $206.14 | 2019-2023 | Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Edwards Lifesciences Corporation | $200.74 | 2021-2025 | Mitris Resilia Mitral Valve, Carpentier-Edwards Physio II Annuloplasty Ring, Konect Resilia |
| Medtronic Vascular, INC. | $192.33 | 2019 | |
| Merck Sharp & Dohme LLC | $134.37 | 2019-2024 | Bridion |
| Heron Therapeutics, INC. | $124.77 | 2022 | |
| Baxter Healthcare | $115.52 | 2021 | |
| Biosense Webster, INC. | $50.00 | 2019 | |
| Abiomed | $49.14 | 2022 | |
| Boston Scientific Corporation | $41.54 | 2021 | |
| Atricure, INC. | $16.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Himaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.